The Evaluation of the Curative Effect of Electrophysiological Rehabilitation Services on Endometrial Repair After Induced Abortion

NCT06867133 · tracked via the Priya Life Science China tracker

Sponsor

Peking Union Medical College Hospital

Phase

Not applicable

Started

2025-03-31

Last updated

2025-03-10

Condition(s) studied

Endometrium

Investigational drug(s) / intervention(s)

Electrophysiological rehabilitation

Electrophysiological rehabilitation: On the basis of treatment in the control group, postoperative electrophysiological rehabilitation services were started for 30 minutes each time, once a day, for 6 consecutive days as one course of treatment, for a total of one course of treatment. The patch is located at the projection site of the lower abdomen uterus as shown in the figure, simulating bioelectric stimulation parameters: biphasic pulse current, frequency 2Hz, pulse width 3ms. Simultaneously conducting family health education, including but not limited to: 1. Guidance on postoperative physical recovery after abortion: provide advice on postoperative care, nutrition, activity, and personal hygiene; 2. Introduction to contraceptive methods: Introduce the advantages and disadvantages of various contraceptive methods, and help patients choose the most suitable contraceptive method for themselves; 3. Other related health education: including fertility planning and the best time to conceive again.

Study summary

Exploring the efficacy evaluation of electrophysiological rehabilitation services in endometrial repair after induced abortion, providing scientific basis for medical institutions and government post abortion care decision-making.

This study is a multicenter randomized controlled intervention study. The main endpoint of the study was the measurement of endometrial thickness by transvaginal ultrasound on days 21-23 after abortion.

Secondary study endpoint:

1. Postoperative uterine contraction pain;
2. Patient satisfaction;
3. Menstrual recurrence time;
4. Changes in menstrual flow for two consecutive periods after surgery;
5. The duration of two consecutive menstrual periods after surgery.

Eligibility

Sex

FEMALE

Min age

18 Years

Max age

40 Years

Healthy volunteers

Accepted

Inclusion Criteria: 1. Female aged 18-40 years old; 2. Previous menstrual patterns; 3. Pregnancy duration 6-10 weeks; 4. Ultrasound indicates intrauterine pregnancy; 5. Voluntarily accepting surgical induced abortion with no contraindications for induced abortion; 6. Voluntarily participate in the trial and sign the informed consent form. 7. Patients or their families are able to understand the research protocol and are willing to participate in this study, providing written informed consent. Exclusion Criteria: 1. Medical abortion patients; 2. Patients with pelvic and abdominal benign and malignant tumors and other systemic diseases; C) Skin problems such as ulceration, infection, and blisters at the treatment site; d) Patients with missed miscarriage diagnosed clinically; e) Patients with combined uterine fibroids, adenomyosis, and uterine malformations; f) Those who have inserted intrauterine devices (including copper containing intrauterine devices and levonorgestrel containing intrauterine devices); g) Individuals who have had three or more previous induced abortions; h) Clinical diagnosis of thin endometrium; i) Individuals with a history of cesarean section surgery; j) Individuals with severe mental illnesses; k) Researchers determine other situations that are not suitable for participating in this study; l) Patients or their families are unable to understand the conditions and objectives of this study.

Primary outcome measure(s)

Transvaginal ultrasound examination is used to measure the thickness of the endometrium. — On the 21st to 23rd day after abortion.
On the 21st to 23rd day after abortion, vaginal ultrasound was used to measure endometrial thickness.

Trial sites (1)

Facility	City	Region	Status
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences	Beijing	China

More Peking Union Medical College Hospital trials in China

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors Recruiting

Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT Recruiting

Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15) Recruiting

An Observational Cohort Study to Obese Patients With Weight Cycling Active, not recruiting

A Comparative Analysis of Mid- to Long-Term Outcomes: Paclitaxel-Coated Balloon With Debulking Versus Paclitaxel-Coated Balloon Alone in the Treatment of Chronic Femoropopliteal Artery Occlusions Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06867133 on ClinicalTrials.gov ↗ ← All trials in China